Crossmark

Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance?

Crossref DOI link: https://doi.org/10.1016/j.htct.2026.106257

Published Print: 2026-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Omar, Musab MA https://orcid.org/0000-0002-3661-2581
Alanazi, Majed A

Jackson, Denise E. https://orcid.org/0000-0001-9044-8009
License Information

Text and Data Mining valid from 2026-04-01

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2026-01-21
More Information

This article is maintained by: Elsevier

Article Title: Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance?

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2026.106257

Content Type: article

Copyright: © 2026 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.